AR_Logo_tm-021.jpg
Liquid Biopsy Market 2022 Top Leading Players, Recent Developments, Opportunities, Size, Revenue, Sales, Regional Analysis, Business Strategies, Challenges, Types, Applications
April 07, 2022 02:17 ET | Absolute Reports Pvt Ltd
Pune, April 07, 2022 (GLOBE NEWSWIRE) -- Global Liquid Biopsy Market report is expert study that can deliver you with an elaborate analysis of the Liquid Biopsy. The report covers information about...
Logo.png
Cancer Diagnostics Market is Expected to Surpass USD 185 Billion by 2026, Assesses DelveInsight
April 04, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, April 04, 2022 (GLOBE NEWSWIRE) -- Cancer Diagnostics Market is Expected to Surpass USD 185 Billion by 2026, Assesses DelveInsight The Cancer Diagnostics market size is anticipated...
22157.jpg
Global Liquid Biopsy Market Research Report 2022: Liquid Biopsy Enters Exponential Growth Phase as Pandemic Subsides
March 29, 2022 04:08 ET | Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and...
Inivata_CMYK_Logo.jpg
Inivata and Collaborators Publish Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung Cancer
March 17, 2022 03:00 ET | Inivata
Inivata and Collaborators Publish Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung Cancer Study further highlights potential of RaDaR to stratify patients and improve treatment...
Inivata_CMYK_Logo.jpg
Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR™ in Head and Neck Squamous Cell Carcinoma
February 11, 2022 02:00 ET | Inivata
Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaRTM in Head and Neck Squamous Cell Carcinoma RaDaR demonstrated 100% specificity in patients with no...
22157.jpg
Outlook on the Genomic Cancer Panel and Profiling Global Market - Featuring 10x Genomics, Abbott Diagnostics and AccuraGen Among Others
January 28, 2022 05:13 ET | Research and Markets
Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Screening potential Market Size,...
Inivata_CMYK_Logo.jpg
Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program
January 11, 2022 07:00 ET | Inivata
Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program Research Triangle Park, NC, USA and Cambridge, UK, 11 January 2022 -- Inivata, a leader...
22157.jpg
Global Liquid Biopsy Markets 2021-2028: Impact of COVID-19, Initiatives, Funding, Major Deals, and Recent Developments
December 30, 2021 09:28 ET | Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional &...
TIP_link_300x300.jpg
Biopsy Devices Market Size Worth $3,584.20 Million, Globally, by 2027 at 6.2% CAGR - Exclusive Report by The Insight Partners
December 17, 2021 05:44 ET | The Insight Partners
New York, Dec. 17, 2021 (GLOBE NEWSWIRE) -- According to the new market research report "Biopsy Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Needle-Based Biopsy,...
Inivata_CMYK_Logo.jpg
Inivata Appoints David Eberhard MD, PhD as Chief Medical Officer
December 13, 2021 07:00 ET | Inivata
Inivata Appoints David Eberhard MD, PhD as Chief Medical Officer Research Triangle Park, NC, USA and Cambridge, UK, 13 December 2021 -- Inivata, a leader in liquid biopsy, today announced the...